Vincent Chu

Vincent Chu is a Research Scientist at C4 Therapeutics, Inc. with a background in Chemistry and Chemical Biology. Previously, they have conducted research at prestigious institutions such as Harvard Medical School, Princeton University, and The University of Melbourne. Vincent's work has focused on protein degradation pathways, cellular assays, molecular cloning, and biochemical assays. Their experience also includes investigating the role of 1-methylnicotinamide on adipocyte metabolism and synthesizing quantum dots for biolabeling applications.